Company KALA BIO, Inc. Deutsche Boerse AG

Equities

27F0

US4831192020

Pharmaceuticals

Real-time Estimate Tradegate 12:00:00 01/07/2024 BST 5-day change 1st Jan Change
6.695 EUR +8.16% Intraday chart for KALA BIO, Inc. +30.50% -2.04%

Business Summary

KALA BIO, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of therapies for rare and severe diseases of the eye. The Company’s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. The Company’s product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived bio factors, such as growth factors, protease inhibitors, matrix proteins and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its KPI-012 is used for the treatment of persistent corneal epithelial defect (PCED), a rare disease of impaired corneal healing. The Company is also engaged in the development of KPI-012 for the treatment of Limbal Stem Cell Deficiency and other rare corneal diseases.

Number of employees: 43

Managers

Managers TitleAgeSince
Chief Executive Officer 57 28/02/15
Director of Finance/CFO 48 31/01/14
President 53 19/11/17
Compliance Officer 51 02/04/18
Chief Tech/Sci/R&D Officer 71 31/01/13
Investor Relations Contact - -
Corporate Officer/Principal 45 14/11/21

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 27/09/17
Director/Board Member 63 04/03/18
Director/Board Member 66 05/01/14
Director/Board Member 70 14/10/21
Director/Board Member 73 14/11/21
Chief Executive Officer 57 28/02/15
Director/Board Member 50 30/10/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 2,928 0 0 91.40 %
Stock B 1 2,816,454 2,574,136 ( 91.40 %) 0
Stock C 0 51,246 0 0

Shareholders

NameEquities%Valuation
Baker Bros. Advisors LP
9.466 %
266,613 9.466 % 2 M €
Lagunita Biosciences LLC
5.981 %
168,454 5.981 % 1 M €
Millennium Management LLC
4.737 %
133,403 4.737 % 896 468 €
Longitude Capital Management Co LLC
3.843 %
108,239 3.843 % 727 366 €
UBS O'Connor LLC
2.576 %
72,554 2.576 % 487 563 €
72,451 2.572 % 486 871 €
Vanguard Global Advisers LLC
1.491 %
41,981 1.491 % 282 112 €
BlackRock Institutional Trust Co. NA
0.9518 %
26,806 0.9518 % 180 136 €
24,689 0.8766 % 165 910 €
24,154 0.8576 % 162 315 €
NameEquities%Valuation
Baker Bros. Advisors LP
-
51,246 - 344 373 €

Company contact information

KALA BIO, Inc.

1167 Massachusetts Avenue

02476, Arlington

+781 996 5252

http://www.kalarx.com
address KALA BIO, Inc.(27F0)